Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 273,966 | 304,016 | 352,688 | 273,451 | 310,039 |
| Receivables | 14,418 | 11,269 | 8,397 | 7,262 | 4,970 |
| Inventories | 1,325 | 704 | 979 | 969 | 925 |
| Other current assets | 11,428 | 24,918 | 23,578 | 7,705 | 8,277 |
| TOTAL | $301,137 | $340,907 | $385,642 | $289,387 | $324,211 |
| Non-Current Assets | |||||
| PPE Net | 227,227 | 224,380 | 203,027 | 178,602 | 152,499 |
| Intangibles | 3,279 | 3,844 | 3,139 | 4,377 | 4,743 |
| Other Non-Current Assets | 11,334 | 11,320 | 11,308 | 11,326 | 11,357 |
| TOTAL | $241,840 | $239,544 | $217,474 | $194,305 | $168,599 |
| Total Assets | $542,977 | $580,451 | $603,116 | $483,692 | $492,810 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 6,707 | 0 | 0 |
| Accounts payable and accrued liabilities | 11,206 | 13,679 | 10,819 | 10,680 | 9,607 |
| Accrued Expenses | 32,952 | 25,792 | 35,053 | 28,220 | 26,901 |
| Other current liabilities | 20,210 | 17,791 | 17,830 | 16,807 | 15,853 |
| TOTAL | $91,214 | $85,820 | $89,998 | $72,866 | $63,669 |
| Non-Current Liabilities | |||||
| Long Term Debt | 160,882 | 158,872 | 345,474 | 0 | 0 |
| Deferred Revenues | 6,852 | 7,057 | 8,075 | 2,090 | 1,952 |
| Other Non-Current Liabilities | 12,203 | 11,295 | 11,338 | 163,322 | 161,856 |
| TOTAL | $465,530 | $456,568 | $432,317 | $329,734 | $306,377 |
| Total Liabilities | $556,744 | $542,388 | $522,315 | $402,600 | $370,046 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 188,896 | 188,562 | 187,532 | 187,212 | 187,012 |
| Common Shares | 189 | 188 | 187 | 187 | 187 |
| Retained earnings | -1,330,429 | -1,267,271 | -1,214,595 | -1,208,844 | -1,158,736 |
| Other shareholders' equity | -4,444 | -3,872 | -4,185 | -1,291 | -1,451 |
| TOTAL | $-13,767 | $38,063 | $80,801 | $81,092 | $122,764 |
| Total Liabilities And Equity | $542,977 | $580,451 | $603,116 | $483,692 | $492,810 |